StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Merck (MRK), Lilly (LLY), Pfizer (PFE) Weakness Continues as Biotech Shares Get Hit Again
April 18, 2019 10:23 AM
Merck (NYSE: MRK), Lilly ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Merck (MRK) Reports FDA Approval of KEYTRUDA (pembrolizumab) in Combination With Inlyta®= (axitinib)
April 22, 2019 6:46 AM
Pfizer (PFE). Eli Lilly & Co. (NYSE:LLY) Report Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis
April 18, 2019 5:06 PM